323 results
Page 4 of 17
424B5
kmzyq
28 Aug 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
2yf fu14e
20 Jul 20
Soligenix Issues Corporate Update – Highlights Important Catalysts for Second Half of 2020
7:00am
8-K
EX-99.1
hze 9wowr5fvtqix
30 Apr 20
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
7:05am
424B5
9ju5q1o dz5555
10 Apr 20
Prospectus supplement for primary offering
4:16pm
424B5
5srdee4y8ltr1sw2pb4
20 Mar 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
cc5hn848q nyar7eone
19 Mar 20
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
6:04am
8-K
EX-99.1
86l4jaxfw25qzz
14 Jan 20
Soligenix – Advancing to Important Inflection Points
1:05pm
8-K
EX-10.1
yxvqk0rin8cq2swj
3 Jan 20
Departure of Directors or Certain Officers
4:30pm
8-K
nvbqvm1yr3xh ewj6un
3 Jan 20
Departure of Directors or Certain Officers
4:30pm